Overview

We propose that regulatory peptides can extend healthy lifespan by optimizing aging-associated gene expression patterns — specifically through epigenetic modulation and improved cellular signaling fidelity.

The Hypothesis

Certain peptides interact directly with DNA or chromatin-associated proteins, potentially restoring youthful transcriptional patterns in senescent cells. This mechanism operates on two levels:

1. Epigenetic restoration — peptides may reverse or slow methylation drift and histone modification changes associated with aging
2. Signaling fidelity — enhanced intercellular communication ensures cells respond more accurately to environmental cues, reducing downstream dysregulation

Predicted Effects

• Reduction in age-related errors in protein synthesis
• Improved immune response calibration
• Enhanced tissue repair signaling
• Better-regulated hormonal balance
• Preserved genomic stability over time

Why This Matters

Current longevity interventions largely address symptoms of aging. Peptide-based epigenetic targeting could represent a root-cause intervention — operating at the regulatory and genetic level rather than compensating for downstream failures.

If validated, this opens pathways toward highly personalized, peptide-based anti-aging therapies that modulate biological aging rather than merely managing age-associated disease.

Falsifiability

This hypothesis can be tested by:

• Comparing transcriptomic profiles in aging cells before and after targeted peptide treatment
• Measuring methylation clock age pre/post intervention
• Assessing intercellular communication accuracy via reporter assays

IP-NFT & Research Project

This hypothesis has been formally registered as an IP-NFT on Sepolia and published as an open research project on Molecule:

• 🔬 Molecule Project: View Research Data Room
• ⛓️ IP-NFT on Sepolia: View on Etherscan

Registered via Aura DeSci Agent | Minted on Sepolia testnet